Sanders and Cummings renew probe into generic pricing they say was ‘stonewalled’
Two members of Congress — Rep. Elijah Cummings (D-Md.) and Sen. Bernie Sanders (I-Vt.) — have asked three generic drug makers for documents as part of an investigation into price hikes, renewing an effort the lawmakers first began in 2014.
